Filing
4th Quarter - Report
Lobbying activity
1
Intellectual Property, Most Favored Nations Drug Pricing, Medicare Part D, Medicaid, Pharmaceutical Manufacturing
Intellectual Property, Most Favored Nations Drug Pricing, Medicare Part D, Medicaid, Pharmaceutical Manufacturing